Home » Newsletters » BioWorld Science

BioWorld Science

March 3, 2022

View Archived Issues

Researchers present CX-10759 anti-IgE antibody for hypersensitivity

RUNX1 targeting shows promise for treating aggressive PDAC

Sitryx Therapeutics describes nuclear factor erythroid 2-related factor 2 activators

New SLC10A2/SLC10A1 inhibitors identified at Albireo

Ruhr University Bochum presents new compounds for treating axonal damage

Roche divulges new TLR7/8/9 antagonists

Eoetvoes Lorand Tudomanyegyetem, Semmelweis University patent imipridone derivatives

Immunotherapies targeting WT137-45 may avoid acute myeloid leukemia immune evasion

BBP-671 restores brain glutamate/glutamine levels in preclinical model of coenzyme A deficiency

Novel propolis-derived CREB/CRTC2 inhibitor ameliorates metabolic syndrome in obese mice

NTLA-2002 shows promising preclinical results in a partial hepatectomy-induced HAE model

RedCloud cleared to enter clinic with next-generation EGFR inhibitor H-002 for NSCLC

Novel IL-33-dependent mouse model of eosinophilic esophagitis

Adagene and Sanofi collaborate on masked monoclonal and bispecific antibodies for immuno-oncology

PMN-310 shows cognitive benefit in mouse model of Alzheimer's disease

9 Meters collaborates with NYU Langone Health to evaluate NM-102 for autoimmune disorder

Intranasal COVID-19 booster BW-1019 provides protection and boosts immune response in hamsters

Infection in thymus causes autoimmunity in stomach

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...